Bisoprolol/amlodipine combination therapy improves blood pressure control in patients with essential hypertension following monotherapy failure.
CONCLUSIONS: Bisoprolol/amlodipine FDC therapy is associated with significant BP improvements in patients with essential hypertension following monotherapy failure.
PMID: 27334671 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Bisoprolol | Cardiology | Cardiovascular | Heart | Hypertension | Montenegro Health | Norvasc | Research | Study